Skip to content
Avience Biomedicals logo

Avience Biomedicals

AVIENCE NSE
₹242.90 −7.10 (−2.84%)
View as Markdown
MCP
Close 4 Nov 2026 ₹242.90 −172.05 −41.5% since 25 Jun 2026
Start ₹414.95

Key Fundamentals

SMEMedical Equipment & SuppliesHealthcare

Price-based figures as of · TTM

ROCE
27.00%
Debt to Equity
0.92
EPS (TTM)
—
Book Value
₹164.88
Market Cap
—
P/E (TTM)
—
P/B
1.47
ROE
32.30%
Dividend Yield
0.00%
EBITDA
₹15.20 Cr
52W High
₹414.95
52W Low
₹222.00
Day Range
₹242.25 – ₹250.00
Volume
8,400

Peer Comparison

Healthcare › Healthcare Equipment & Supplies › Medical Equipment & Supplies

Avience Biomedicals peer comparison
Molbio Diagnostics
₹1,381.80123.38₹15,607 Cr11.630.00%13.80%18.00%₹1,077 Cr₹125 Cr
Poly Medicure
₹1,586.8051.04₹15,325 Cr5.180.23%9.02%12.50%₹1,997 Cr₹313 Cr
Fischer Medical Ventures
₹25.2366.39₹1,611 Cr3.610.20%8.91%11.40%₹367 Cr₹24 Cr
Tarsons Products
₹311.10148.85₹1,603 Cr2.610.67%2.44%4.59%₹441 Cr₹11 Cr
Q-Line Biotech
₹527.1524.98₹1,243 Cr2.520.00%26.00%22.40%₹201 Cr₹34 Cr
Laxmi Dental
₹188.7133.64₹1,017 Cr4.270.00%14.80%15.00%₹287 Cr₹31 Cr
Hemant Surgical Industries
₹608.10—₹868 Cr5.640.00%16.90%18.90%——
Avience Biomedicals (this company)
₹242.90—₹137 Cr1.470.00%32.30%27.00%——
Median 8 companies₹419.1358.72₹1,423 Cr3.940.00%14.30%16.50%₹404 Cr₹33 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Key Insights

Strengths

1
  • Company has a good return on equity (ROE) track record: 3 Years ROE 37.9%

Weaknesses

1
  • Company might be capitalizing the interest cost

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallBearish8101
OscillatorsBearish261
Moving AveragesStrong Bearish640

Key readings

RSI (14)
37.76
Neutral
MACD (12,26,9)
−14.55
Bearish
SMA (50)
293.77
Bearish
SMA (200)
—
Neutral

As of

Growth Rate

From the financial statements below. 1Y: fiscal year to Mar 2026 against Mar 2025.

Revenue

Revenue growth by window
1Y+16.79%

Net profit

Net profit growth by window
1Y+23.24%

Operating cash flow

Operating cash flow growth by window
1Y+74.34%

Operating margin· change in pp

Operating margin growth by window
1Y+3.13 pp

Trailing twelve months: Results are not reported for each of the last eight quarters, so there is no trailing-twelve-month figure.

Revenue by year

Revenue by year, ₹ crore
Mar 2024₹23.83 Cr
Mar 2025₹44.92 Cr
Mar 2026₹52.46 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2024₹2.16 Cr
Mar 2025₹7.10 Cr
Mar 2026₹8.75 Cr

Half-yearly Results

₹ Cr
AVIENCE half-yearly results, ₹ crore
Particulars Mar 2025Sep 2025Mar 2026
Sales
24.47
26.82
25.69
Expenses
17.86
19.57
18
Operating Profit
6.61
7.25
7.69
OPM %
27.01%
27.03%
29.93%
Other Income
0.46
0.06
0.23
Interest
0.69
0.65
0.89
Depreciation
0.48
0.56
0.66
PBT
5.9
6.1
6.37
Tax %
27.63%
25.74%
33.75%
Net Profit
4.27
4.54
4.22
EPS (₹)
10.59
11.26
10.47

Profit & Loss

₹ Cr
AVIENCE profit and loss, annual, ₹ crore
Particulars Mar 2024Mar 2025Mar 2026
Sales
23.83
44.92
52.46
Expenses
19.65
33.4
37.36
Operating Profit
4.18
11.52
15.1
OPM %
17.54%
25.65%
28.78%
Other Income
0.41
0.58
0.29
Interest
0.94
1.45
1.7
Depreciation
0.62
0.88
1.22
PBT
3.03
9.77
12.47
Tax %
28.71%
27.33%
29.75%
Net Profit
2.16
7.1
8.75
EPS (₹)
6.58
17.61
21.71
Div. Payout %
0%
0%
0%

Balance Sheet

₹ Cr
AVIENCE balance sheet, annual, ₹ crore
Particulars Mar 2024Mar 2025Mar 2026
Equity Capital
3.28
4.03
4.03
Reserves
2.94
18.63
27.38
Borrowings
15.13
22.16
28.93
Other Liabilities
13.18
11.6
14.2
Total Liabilities
34.53
56.42
74.54
Fixed Assets
10.25
13.1
16.06
CWIP
0.03
4.62
12.85
Investments
0.03
0.03
0.03
Other Assets
24.22
38.67
45.6
Total Assets
34.53
56.42
74.54

Cash Flow

₹ Cr
AVIENCE cash flow, annual, ₹ crore
Particulars Mar 2024Mar 2025Mar 2026
Operating
1.02
3.39
5.91
Investing
−3.9
−9.54
−13.27
Financing
2.93
10.21
5.42
Net Cash Flow
0.05
4.06
−1.95
Free Cash Flow
−2.81
−5.87
−7.44
CFO/OP
29
36
58

Ratios

AVIENCE financial ratios, annual
Particulars Mar 2024Mar 2025Mar 2026
Debtor Days
124
140
146
Inventory Days
290
176
218
Days Payable
130
98.06
120
Cash Conversion Cycle
284
218
244
Working Capital Days
28.64
70.29
74.1
ROCE %
—
34.18%
26.95%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Avience Biomedicals insights

52 extracted metrics across FY24–FY26.

Shareholding Pattern

As of Sep 2026

  • Promoters 64.59%
  • Public 18.37%
  • Others 13.52%
  • DIIs 3.48%
  • FIIs 0.03%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Documents

Frequently Asked Questions about Avience Biomedicals

What does Avience Biomedicals Ltd do?
Incorporated in June 2024, Avience Biomedicals Limited is an ISO certified company specializing in manufacturing, supplying, and exporting molecular diagnostic solutions.
Where is Avience Biomedicals Ltd (AVIENCE) listed?
Avience Biomedicals Ltd trades as AVIENCE on the NSE.
Which sector does Avience Biomedicals Ltd belong to?
Avience Biomedicals Ltd is classified under the Healthcare sector, in the Healthcare Equipment & Supplies industry.
What is the 52-week high and low of Avience Biomedicals Ltd?
Over the last 52 weeks Avience Biomedicals Ltd has traded between ₹222 and ₹414.95 as of 4 Nov 2026.
What is the Return on Equity (ROE) of Avience Biomedicals Ltd?
Avience Biomedicals Ltd reported a return on equity of 32.30%. Its debt-to-equity ratio is 0.92.

Company Information

Incorporated in June 2024, Avience Biomedicals Limited is an ISO certified company specializing in manufacturing, supplying, and exporting molecular diagnostic solutions.

Website avienbio.com
Listed 25 Jun 2026
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/AVIENCE.md for Avience Biomedicals Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month